Evidence map›Paper›PMID 35642585›Full record

ArticleEMBO reports2022

Malaria parasites release vesicle subpopulations with signatures of different destinations.

Paula Abou Karam, Irit Rosenhek-Goldian, Tamar Ziv, Hila Ben Ami Pilo, Ido Azuri, Anna Rivkin, Edo Kiper, Ron Rotkopf, Sidney R Cohen, Ana Claudia Torrecilhas and 4 more

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Interaction ofiScience · 2026
    Article
  2. Laurdan: Clarifying Photophysics and Advancing the Characterization of Extracellular Vesicles.Chemphyschem : a European journal of chemical physics and physical chemistry · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Erythropoiesis and Malaria, a Multifaceted Interplay.International journal of molecular sciences · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Paula Abou KaramDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Irit Rosenhek-GoldianDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-4878-5359
Tamar ZivSmoler Proteomics Center, Department of Biology, Technion - Israel Institute of Technology, Haifa, Israel.ORCID 0000-0003-4299-7454
Hila Ben Ami PiloDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Ido AzuriBioinformatics Unit, Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-2891-1514
Anna RivkinDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Edo KiperDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Ron RotkopfBioinformatics Unit, Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Sidney R CohenDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0003-4255-3351
Ana Claudia TorrecilhasDepartment of Pharmaceutical Sciences, Federal University of São Paulo, UNIFESP, Diadema, Brazil.ORCID 0000-0001-5724-2199
Ori AvinoamDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0003-3543-168X
Alicia RojasLaboratory of Helminthology, Faculty of Microbiology, University of Costa Rica, San José, Costa Rica.ORCID 0000-0003-2007-7198
Mattia I MorandiDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0001-8467-4552
Neta Regev-RudzkiDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0001-7252-0193
Weizmann Institute of Science · ILTechnion – Israel Institute of Technology · ILUniversidad de Costa Rica · CRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria is the most serious mosquito-borne parasitic disease, caused mainly by the intracellular parasite Plasmodium falciparum. The parasite invades human red blood cells and releases extracellular vesicles (EVs) to alter its host responses. It becomes clear that EVs are generally composed of sub-populations. Seeking to identify EV subpopulations, we subject malaria-derived EVs to size-separation analysis, using asymmetric flow field-flow fractionation. Multi-technique analysis reveals surprising characteristics: we identify two distinct EV subpopulations differing in size and protein content. Small EVs are enriched in complement-system proteins and large EVs in proteasome subunits. We then measure the membrane fusion abilities of each subpopulation with three types of host cellular membranes: plasma, late and early endosome. Remarkably, small EVs fuse to early endosome liposomes at significantly greater levels than large EVs. Atomic force microscope imaging combined with machine-learning methods further emphasizes the difference in biophysical properties between the two subpopulations. These results shed light on the sophisticated mechanism by which malaria parasites utilize EV subpopulations as a communication tool to target different cellular destinations or host systems.

Indexed as

Extracellular VesiclesMalariaParasitesAnimalsErythrocytesHumansPlasmodium falciparumAFMasymmetric flow field-flow fractionationextracellular vesiclesmalariamembrane fusion

Identifiers

PMID35642585
PMCPMC9253735
OpenAlexW4281613070

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.